| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―11 |
Engineering Komagataella phaffii for secreted and surface-displayed production of SARS-CoV-2 receptor-binding domain and its immunogenicity evaluation |
Kostyantyn Dmytruk, Olena Dmytruk, Marta Semkiv, Roksolana Vasylyshyn, Lyubov Fayura, Lidia Gaffke, Magdalena Podlacha, Zuzanna Cyske, Karolina Pierzynowska, Patrick Budylowski, Mario Ostrowski, Grzegorz Wegrzyn, Andriy Sibirny |
| 2 |
[GO] |
2024―Feb―06 |
Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19 |
Norma A. Valdez-Cruz, Diego Rosiles-Becerril, Constanza E. Martínez-Olivares, Enrique García-Hernández, Laura Cobos-Marín, Daniel Garzón, Francisco E. López-Salas, Guadalupe Zavala, Axel Luviano, Alejandro Olvera, Alejandro Alagón, Octavio T. Ramírez, Mauricio A. Trujillo-Roldán |
| 3 |
[GO] |
2023―May―10 |
Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice |
In-Chan Hwang, Valerie Diane Valeriano, Ji Hoon Song, Marcela Pereira, Ju Kyoung Oh, Kyudong Han, Lars Engstrand, Dae-Kyung Kang |
| 4 |
[GO] |
2023―Feb―25 |
Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice |
Sima Sazegari, Malihe Akbarzadeh Niaki, Alireza Afsharifar, Ali Niazi, Abdollah Derakhshandeh, Maryam Moradi Vahdat, Farshad Hemmati, Mohammad Hadi Eskandari |
| 5 |
[GO] |
2022―Feb―05 |
Escherichia coli recombinant expression of SARS-CoV-2 protein fragments |
Bailey E. McGuire, Julia E. Mela, Vanessa C. Thompson, Logan R. Cucksey, Claire E. Stevens, Ralph L. McWhinnie, Dirk F. H. Winkler, Steven Pelech, Francis E. Nano |
| 6 |
[GO] |
2021―May―05 |
Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice |
Tong Gao, Yi Ren, Shuangqin Li, Xin Lu, Han Lei |
| 7 |
[GO] |
2021―Apr―22 |
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment |
Norma A. Valdez-Cruz, Enrique García-Hernández, Clara Espitia, Laura Cobos-Marín, Claudia Altamirano, Carlos G. Bando-Campos, Luis F. Cofas-Vargas, Enrique W. Coronado-Aceves, Ricardo A. González-Hernández, Pablo Hernández-Peralta, Daniel Juárez-López, Paola A. Ortega-Portilla, Sara Restrepo-Pineda, Patricio Zelada-Cordero, Mauricio A. Trujillo-Roldán |
| 8 |
[GO] |
2020―Nov―26 |
Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19 |
Taha Baghbani, Hossein Nikzad, Javid Azadbakht, Fatemeh Izadpanah, Hamed Haddad Kashani |
|
